Corcept Therapeutics IncorporatedCorcept Therapeutics IncorporatedCorcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

No trades
See on Supercharts
Market capitalization
‪2.31 B‬USD
‪105.50 M‬USD
‪482.38 M‬USD
‪89.19 M‬
Beta (1Y)
0.56

About Corcept Therapeutics Incorporated

CEO
Joseph K. Belanoff
Headquarters
Menlo Park
Employees (FY)
352
Founded
1998
FIGI
BBG000BKJG33
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CORT is 22.35 USD — it has decreased by 2.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Corcept Therapeutics Incorporated stocks are traded under the ticker CORT.
Corcept Therapeutics Incorporated is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
CORT stock is 5.62% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is Corcept Therapeutics Incorporated there?
CORT earnings for the last quarter are 0.28 USD per share, whereas the estimation was 0.22 USD resulting in a 28.24% surprise. The estimated earnings for the next quarter are 0.26 USD per share. See more details about Corcept Therapeutics Incorporated earnings.
Corcept Therapeutics Incorporated revenue for the last quarter amounts to ‪123.60 M‬ USD despite the estimated figure of ‪119.71 M‬ USD. In the next quarter revenue is expected to reach ‪129.27 M‬ USD.
Yes, you can track Corcept Therapeutics Incorporated financials in yearly and quarterly reports right on TradingView.
CORT stock has fallen by 4.97% compared to the previous week, the month change is a 9.66% fall, over the last year Corcept Therapeutics Incorporated has showed a 0.31% decrease.
CORT net income for the last quarter is ‪31.14 M‬ USD, while the quarter before that showed ‪31.17 M‬ USD of net income which accounts for −0.11% change. Track more Corcept Therapeutics Incorporated financial stats to get the full picture.
Today Corcept Therapeutics Incorporated has the market capitalization of ‪2.38 B‬, it has decreased by 4.66% over the last week.
No, CORT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CORT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Corcept Therapeutics Incorporated stock right from TradingView charts — choose your broker and connect to your account.
CORT reached its all-time high on Sep 14, 2023 with the price of 34.28 USD, and its all-time low was 0.68 USD and was reached on Oct 12, 2006.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 352.00 employees. See our rating of the largest employees — is Corcept Therapeutics Incorporated on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Corcept Therapeutics Incorporated technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Corcept Therapeutics Incorporated stock shows the sell signal. See more of Corcept Therapeutics Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Corcept Therapeutics Incorporated future price: according to them, CORT price has a max estimate of 61.00 USD and a min estimate of 35.00 USD. Read a more detailed Corcept Therapeutics Incorporated forecast: see what analysts think of Corcept Therapeutics Incorporated and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Corcept Therapeutics Incorporated EBITDA is ‪109.59 M‬ USD, and current EBITDA margin is 22.46%. See more stats in Corcept Therapeutics Incorporated financial statements.